MIRA Pharmaceuticals Statistics
Total Valuation
MIRA has a market cap or net worth of $18.22 million. The enterprise value is $14.07 million.
| Market Cap | 18.22M |
| Enterprise Value | 14.07M |
Important Dates
The next estimated earnings date is Monday, March 31, 2025, before market open.
| Earnings Date | Mar 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MIRA has 16.56 million shares outstanding. The number of shares has increased by 9.59% in one year.
| Current Share Class | 16.56M |
| Shares Outstanding | 16.56M |
| Shares Change (YoY) | +9.59% |
| Shares Change (QoQ) | +1.97% |
| Owned by Insiders (%) | 20.84% |
| Owned by Institutions (%) | 5.63% |
| Float | 10.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.01 |
| P/TBV Ratio | 5.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.11
| Current Ratio | 6.11 |
| Quick Ratio | 5.98 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.16 |
Financial Efficiency
Return on equity (ROE) is -192.32% and return on invested capital (ROIC) is -91.51%.
| Return on Equity (ROE) | -192.32% |
| Return on Assets (ROA) | -81.27% |
| Return on Invested Capital (ROIC) | -91.51% |
| Return on Capital Employed (ROCE) | -241.68% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.75M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.80% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +2.80% |
| 50-Day Moving Average | 1.17 |
| 200-Day Moving Average | 1.28 |
| Relative Strength Index (RSI) | 43.36 |
| Average Volume (20 Days) | 226,500 |
Short Selling Information
The latest short interest is 583,890, so 3.53% of the outstanding shares have been sold short.
| Short Interest | 583,890 |
| Short Previous Month | 647,612 |
| Short % of Shares Out | 3.53% |
| Short % of Float | 5.52% |
| Short Ratio (days to cover) | 1.65 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.64M |
| Pretax Income | -12.36M |
| Net Income | -11.24M |
| EBITDA | n/a |
| EBIT | -8.64M |
| Earnings Per Share (EPS) | -$0.57 |
Balance Sheet
| Cash & Cash Equivalents | 4.14M |
| Total Debt | n/a |
| Net Cash | 4.14M |
| Net Cash Per Share | $0.25 |
| Equity (Book Value) | 3.57M |
| Book Value Per Share | 0.22 |
| Working Capital | 3.54M |
Cash Flow
| Operating Cash Flow | -4.79M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.79M |
| FCF Per Share | -$0.29 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MIRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.59% |
| Shareholder Yield | -9.59% |
| Earnings Yield | -61.70% |
| FCF Yield | -26.30% |
Analyst Forecast
The average price target for MIRA is $14.00, which is 1,172.73% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.00 |
| Price Target Difference | 1,172.73% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |